Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04274543 · ClinicalTrials.gov registry record · Phase 2

Ultrasound-Guided Injections for Meniscal Injuries in Active-Duty Military

A Phase 2 study, sponsored by Kessler Foundation.

Completed
Registry status
Phase 2
Development phase
3
Enrollment target

NCT04274543 is a Phase 2 study that has completed, run by Kessler Foundation. The registered enrollment target is 3 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04274543, a Phase 2 study, has completed, sponsored by Kessler Foundation.

COMPLETED
Registry status
Phase 2
Development phase
3 participants
Enrollment target

Study Summary

Knee injuries are common among active-duty military personnel. One of the most common knee injuries is a meniscus tear, which can have several consequences. Immediately, the soldier may be separated from the military for over one year or assigned a permanent activity limiting duty profile. Over time, meniscal tears may also increase the risk of other knee injuries, such as osteoarthritis, which is one of the most common medical reasons for discharge from active duty service. The current standard of care includes conservative treatments, such as physical therapy and rest. Once conservative treatments fail, surgery is generally the next option. However, there is limited evidence that surgery is effective and some studies suggest it can accelerate the development of osteoarthritis. The goal of this study is to evaluate the efficacy of a regenerative treatment for meniscal tears termed micro-fragmented adipose tissue in reducing pain and restoring activity levels. We will recruit active-duty military personnel and civilians with meniscal tears and provide them with either the adipose tissue treatment or a control treatment consisting of saline. We will then follow these individuals for up to one year and evaluate differences in pain and function between the two groups. The ultimate goal is to show that micro-fragmented adipose tissue is a viable alternative for the treatment of meniscal tears in active-duty military personnel.

Interventions

  • DRUG Normal Saline
  • DEVICE Lipogems

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2019-07-01
Est. Completion 2024-12-01
Phase Phase 2

Sponsor

Kessler Foundation

104 total trials

What the Registry Record Tells You About NCT04274543

The ClinicalTrials.gov registry entry for NCT04274543 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.

NCT04274543 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04274543 about?

NCT04274543 is a clinical study titled "Ultrasound-Guided Injections for Meniscal Injuries in Active-Duty Military". Knee injuries are common among active-duty military personnel. One of the most common knee injuries is a meniscus tear, which can have several consequences. Immediately, the soldier may be separated from the military for over one year or assigned a permanent activity limiting duty profile. Over time...

What is the current status of trial NCT04274543?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2019-07-01. Estimated completion is 2024-12-01.

What interventions are being tested in trial NCT04274543?

The interventions under investigation include: Normal Saline (DRUG), Lipogems (DEVICE).

Who is sponsoring clinical trial NCT04274543?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.